Development of Anticancer Agents Targeting the Hedgehog Signaling
Overview
Authors
Affiliations
Hedgehog signaling is an evolutionarily conserved pathway which is essential in embryonic and postnatal development as well as adult organ homeostasis. Abnormal regulation of Hedgehog signaling is implicated in many diseases including cancer. Consequently, substantial efforts have made in the past to develop potential therapeutic agents that specifically target the Hedgehog signaling for cancer treatment. Here, we review the therapeutic agents for inhibition of the Hedgehog signaling and their clinical advances in cancer treatment.
The role of Hedgehog and Notch signaling pathway in cancer.
Xia R, Xu M, Yang J, Ma X Mol Biomed. 2022; 3(1):44.
PMID: 36517618 PMC: 9751255. DOI: 10.1186/s43556-022-00099-8.
Akalin A, Dedekarginoglu B, Choi S, Han B, Ozcelikkale A Pharm Res. 2022; 40(2):501-523.
PMID: 35650448 PMC: 9712595. DOI: 10.1007/s11095-022-03298-8.
Chang Y, Tam H, Lu M, Huang H PLoS One. 2021; 16(7):e0254011.
PMID: 34237099 PMC: 8266077. DOI: 10.1371/journal.pone.0254011.
A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth.
Lospinoso Severini L, Quaglio D, Basili I, Ghirga F, Bufalieri F, Caimano M Cancers (Basel). 2019; 11(10).
PMID: 31601026 PMC: 6826940. DOI: 10.3390/cancers11101518.
Primary Cilia as Signaling Hubs in Health and Disease.
Nishimura Y, Kasahara K, Shiromizu T, Watanabe M, Inagaki M Adv Sci (Weinh). 2019; 6(1):1801138.
PMID: 30643718 PMC: 6325590. DOI: 10.1002/advs.201801138.